checkAd

     161  0 Kommentare Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization - Seite 3 

    CONTACT: Contacts:

Editas Medicine Media and Investor Contact:
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com 

Azzur Media Contact:
Emily Steinhauer
CGLife, on behalf of Azzur Group
azzurpr@cglife.com
203-218-9906

    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization - Seite 3 CAMBRIDGE, Mass., and DEVENS, Mass., July 27, 2023 (GLOBE NEWSWIRE) - Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, and Azzur Cleanrooms on Demand (COD), an Azzur Group company, today announced the companies have …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer